Literature DB >> 23736922

Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation.

Paolo Perazzo1, Marco Viganò, Laura De Girolamo, Francesco Verde, Anna Vinci, Giuseppe Banfi, Sergio Romagnoli.   

Abstract

BACKGROUND: Blood loss during total joint arthroplasty strongly influences the time to recover after surgery and the quality of the recovery. Blood conservation strategies such as pre-operative autologous blood donation and post-operative cell salvage are intended to avoid allogeneic blood transfusions and their associated risks. Although widely investigated, the real effectiveness of these alternative transfusion practices remains controversial.
MATERIALS AND METHODS: The surgery reports of 600 patients undergoing total joint arthroplasty (312 hip and 288 knee replacements) were retrospectively reviewed to assess transfusion needs and related blood management at our institute. Evaluation parameters included post-operative blood loss, haemoglobin concentration measured at different time points, ASA score, and blood transfusion strategies.
RESULTS: Autologous blood donation increased the odds of receiving a red blood cell transfusion. Reinfusion by a cell salvage system of post-operative shed blood was found to limit adverse effects in cases of severe post-operative blood loss. The peri-operative net decrease in haemoglobin concentration was higher in patients who had predeposited autologous blood than in those who had not. DISCUSSION: The strengths of this study are the high number of cases and the standardised procedures, all operations having been performed by a single orthopaedic surgeon and a single anaesthesiologist. Our data suggest that a pre-operative autologous donation programme may often be useless, if not harmful. Conversely, the use of a cell salvage system may be effective in reducing the impact of blood transfusion on a patient's physiological status. Basal haemoglobin concentration emerged as a useful indicator of transfusion probability in total joint replacement procedures.

Entities:  

Mesh:

Year:  2013        PMID: 23736922      PMCID: PMC3729127          DOI: 10.2450/2013.0197-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  35 in total

1.  Predicting need for allogeneic transfusion after total knee arthroplasty.

Authors:  Manish S Noticewala; Jonathan D Nyce; Wenbao Wang; Jeffrey A Geller; William Macaulay
Journal:  J Arthroplasty       Date:  2012-06       Impact factor: 4.757

Review 2.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  Paul A Carless; David A Henry; Annette J Moxey; Dianne O'Connell; Tamara Brown; Dean A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

3.  A review of nearly two decades in an autologous blood programme: The rise and fall of activity.

Authors:  G Rock; R Berger; J Bormanis; A Giulivi; S ElSaadany; M Afzal; J Beard; D Neurath; T G Jones
Journal:  Transfus Med       Date:  2006-10       Impact factor: 2.019

4.  Limited utility of algorithms predicting blood transfusions.

Authors:  Ralf Karger; Andrea Bornmann; Volker Kretschmer
Journal:  Blood Transfus       Date:  2012-10-29       Impact factor: 3.443

5.  Impact of the economic downturn on adult reconstruction surgery: a survey of the American Association of Hip and Knee Surgeons.

Authors:  Richard Iorio; Charles M Davis; William L Healy; Thomas K Fehring; Mary I O'Connor; Sally York
Journal:  J Arthroplasty       Date:  2010-10       Impact factor: 4.757

6.  Hospital economics of primary THA decreasing reimbursement and increasing cost, 1990 to 2008.

Authors:  Adam J Rana; Richard Iorio; William L Healy
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

7.  Efficacy of preoperative autologous blood donation for elective posterior lumbar spinal surgery.

Authors:  Cian Kennedy; Micheal Leonard; Aiden Devitt; Federico P Girardi; Frank P Cammisa
Journal:  Spine (Phila Pa 1976)       Date:  2011-12-15       Impact factor: 3.468

8.  Nonanemic patients do not benefit from autologous blood donation before total hip replacement.

Authors:  Friedrich Boettner; Eric I Altneu; Brendan A Williams; Matthew Hepinstall; Thomas P Sculco
Journal:  HSS J       Date:  2009-12-05

9.  Limit allogeneic blood use with routine re-use of patient's own blood: a prospective, randomized, controlled trial in total hip surgery.

Authors:  Bregje J W Thomassen; Peter Pilot; Vanessa A B Scholtes; Josef G Grohs; Ketil Holen; Elvira Bisbe; Rudolf W Poolman
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 10.  Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines.

Authors:  L T Goodnough; A Maniatis; P Earnshaw; G Benoni; P Beris; E Bisbe; D A Fergusson; H Gombotz; O Habler; T G Monk; Y Ozier; R Slappendel; M Szpalski
Journal:  Br J Anaesth       Date:  2011-01       Impact factor: 9.166

View more
  9 in total

1.  Preoperative autologous blood donation in lower limb arthroplasty surgery: has the time come for its retirement?

Authors:  Manuel Muñoz; José A García-Erce
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

2.  Aspirin mono-therapy continuation does not result in more bleeding after knee arthroplasty.

Authors:  Pierre-Emmanuel Schwab; Patricia Lavand'homme; JeanCyr Yombi; Emmanuel Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-10-29       Impact factor: 4.342

3.  Onsets of complications and revisions are not increased after simultaneous bilateral unicompartmental knee arthroplasty in comparison with unilateral procedures.

Authors:  Sergio Romagnoli; Sara Zacchetti; Paolo Perazzo; Francesco Verde; Giuseppe Banfi; Marco Viganò
Journal:  Int Orthop       Date:  2014-10-14       Impact factor: 3.075

4.  Simultaneous bilateral total hip arthroplasties do not lead to higher complication or allogeneic transfusion rates compared to unilateral procedures.

Authors:  Sergio Romagnoli; Sara Zacchetti; Paolo Perazzo; Francesco Verde; Giuseppe Banfi; Marco Viganò
Journal:  Int Orthop       Date:  2013-07-24       Impact factor: 3.075

Review 5.  Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials.

Authors:  Qiang Wu; Hong-An Zhang; Shi-Long Liu; Tao Meng; Xin Zhou; Ping Wang
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-11-28

6.  Effects of Pre-Donated Autologous Blood Transfusion on Peri-Operative Hemoglobin Concentration and Mid-Term Health Outcomes in Primary Total Knee Arthroplasty.

Authors:  Jun Tomura; Daichi Morikawa; Masahiko Nozawa; Muneaki Ishijima; Sung-Gon Kim
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

7.  Total hip arthroplasty in patients with haemophilia - What are the risks of bleeding in the immediate peri-operative period?

Authors:  Grainne Colgan; Joseph F Baker; N Donlon; N Hogan; T McCarthy
Journal:  J Orthop       Date:  2016-07-27

8.  Effect of both preoperative andpostoperative cryoceutical treatment on hemostasis and postoperative pain following total knee arthroplasty.

Authors:  Engin Eren Desteli; Yunus Imren; Nuri Aydın
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Postoperative Autologous Reinfusion in Total Knee Replacement.

Authors:  A Crescibene; F Martire; P Gigliotti; A Rende; M Candela
Journal:  J Blood Transfus       Date:  2015-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.